These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 15328823

  • 1. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
    Lipton A.
    J Support Oncol; 2004; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effects of bisphosphonates.
    Green JR.
    Cancer; 2003 Feb 01; 97(3 Suppl):840-7. PubMed ID: 12548584
    [Abstract] [Full Text] [Related]

  • 3. Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo.
    Fournier PG, Daubiné F, Lundy MW, Rogers MJ, Ebetino FH, Clézardin P.
    Cancer Res; 2008 Nov 01; 68(21):8945-53. PubMed ID: 18974139
    [Abstract] [Full Text] [Related]

  • 4. Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates.
    Green JR.
    Acta Oncol; 2005 Nov 01; 44(3):282-92. PubMed ID: 16076701
    [Abstract] [Full Text] [Related]

  • 5. The antitumor potential of bisphosphonates.
    Clézardin P.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):33-42. PubMed ID: 12584693
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec 01; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 7. Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.
    Conte P, Guarneri V.
    Oncologist; 2004 Dec 01; 9 Suppl 4():28-37. PubMed ID: 15459427
    [Abstract] [Full Text] [Related]

  • 8. Toward new horizons: the future of bisphosphonate therapy.
    Lipton A.
    Oncologist; 2004 Dec 01; 9 Suppl 4():38-47. PubMed ID: 15459428
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005 Dec 01; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

  • 10. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A.
    Cancer Treat Rev; 2008 Dec 01; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D, Henschke P, Possinger K.
    Anticancer Res; 2007 Dec 01; 27(4A):1759-68. PubMed ID: 17649770
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonates: clinical experience.
    Coleman RE.
    Oncologist; 2004 Dec 01; 9 Suppl 4():14-27. PubMed ID: 15459426
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and cost of bisphosphonate therapy in tumor bone disease.
    Body JJ.
    Cancer; 2003 Feb 01; 97(3 Suppl):859-65. PubMed ID: 12548587
    [Abstract] [Full Text] [Related]

  • 14. New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.
    Rosen LS.
    Oncology (Williston Park); 2004 May 01; 18(5 Suppl 3):26-32. PubMed ID: 15202585
    [Abstract] [Full Text] [Related]

  • 15. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA.
    Cancer Treat Rev; 2008 May 01; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [Abstract] [Full Text] [Related]

  • 16. Bisphosphonates for treatment and prevention of bone metastases.
    Michaelson MD, Smith MR.
    J Clin Oncol; 2005 Nov 10; 23(32):8219-24. PubMed ID: 16278476
    [Abstract] [Full Text] [Related]

  • 17. The potential role of bisphosphonates in prostate cancer.
    Oades GM, Coxon J, Colston KW.
    Prostate Cancer Prostatic Dis; 2002 Nov 10; 5(4):264-72. PubMed ID: 12627210
    [Abstract] [Full Text] [Related]

  • 18. Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis.
    Vessella RL, Corey E.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 2):6285s-6290s. PubMed ID: 17062715
    [Abstract] [Full Text] [Related]

  • 19. The role of bisphosphonates in breast cancer.
    Coleman RE.
    Breast; 2004 Dec 15; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [Abstract] [Full Text] [Related]

  • 20. [Bisphosphonates in the treatment and prevention of bone metastases].
    Hoekman K, van Holten-Verzantvoort AT, Pinedo HM.
    Ned Tijdschr Geneeskd; 1997 Nov 15; 141(46):2217-22. PubMed ID: 9550782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.